Literature DB >> 12853201

Primary biliary cirrhosis.

Jayant A Talwalkar1, Keith D Lindor.   

Abstract

Primary biliary cirrhosis is a chronic cholestatic liver disease of adults. This disorder is characterised histologically by chronic non-suppurative destruction of interlobular bile ducts leading to advanced fibrosis, cirrhosis, and liver failure. The precise aetiopathogenesis of primary biliary cirrhosis remains unknown, although dysregulation of the immune system and genetic susceptibility both seem to be important. Affected patients are typically middle-aged women with abnormal serum concentrations of alkaline phosphatase. Presence of antimitochondrial antibody in serum is almost diagnostic of the disorder. Identification of primary biliary cirrhosis is important, because effective treatment with ursodeoxycholic acid has been shown to halt disease progression and improve survival without need for liver transplantation. However, therapeutic options for disease-related complications-including fatigue and metabolic bone disease-remain unavailable. Mathematical models have been developed that accurately predict the natural history of primary biliary cirrhosis in individuals. Despite advances in understanding of the disease, it remains one of the major indications for liver transplantation worldwide.

Entities:  

Mesh:

Year:  2003        PMID: 12853201     DOI: 10.1016/S0140-6736(03)13808-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  68 in total

1.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

2.  Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.

Authors:  M Allocca; A Crosignani; A Gritti; G Ghilardi; D Gobatti; D Caruso; M Zuin; M Podda; P M Battezzati
Journal:  Gut       Date:  2006-04-21       Impact factor: 23.059

3.  Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory.

Authors:  J Kwok; B Jones
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

4.  38-year-old woman with abnormal liver enzymes and hyperlipidemia.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Mayo Clin Proc       Date:  2009-06       Impact factor: 7.616

5.  Pregnancy and primary biliary cirrhosis: a case-control study.

Authors:  Annarosa Floreani; Chiara Infantolino; Irene Franceschet; Ivette Magne Tene; Nora Cazzagon; Alessandra Buja; Vincenzo Baldo; M Eric Gershwin; Maria Teresa Gervasi
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  Lack of association between vitamin D receptor gene ApaI, BsmI, and TaqI polymorphisms and primary biliary cirrhosis risk: a meta-analysis.

Authors:  Cuiju Mo; Yu Lu; Yan Deng; Jian Wang; Li Xie; Taijie Li; Yu He; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-02-14

Review 7.  [Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?].

Authors:  J Pausch; M Gatzen
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

8.  The value of antinuclear antibodies in primary biliary cirrhosis.

Authors:  Lixia Gao; Xinping Tian; Bin Liu; Fengchun Zhang
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

9.  A case of primary biliary cirrhosis associated with pernicious anemia: a case report.

Authors:  Elhem Ben Jazia; Mabrouk Khalifa; Atef Ben Abdelkader; Naoufel Kaabia; Neirouz Ghannouchi; Ahlem Braham; Amel Letaief; Fethi Bahri
Journal:  Cases J       Date:  2010-01-08

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.